Advertisement
ADCT vs AXON
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a StrongBuy and AXON is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ADCT’s FA Score shows that 1 FA rating(s) are green whileAXON’s FA Score has 1 green FA rating(s).
- ADCT’s FA Score: 1 green, 4 red.
- AXON’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ADCT’s TA Score shows that 4 TA indicator(s) are bullish while AXON’s TA Score has 5 bullish TA indicator(s).
- ADCT’s TA Score: 4 bullish, 4 bearish.
- AXON’s TA Score: 5 bullish, 4 bearish.
Price Growth
ADCT (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while AXON (@Aerospace & Defense) price change was -12.08% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.88%. For the same industry, the average monthly price growth was +0.21%, and the average quarterly price growth was +13.40%.
The average weekly price growth across all stocks in the @Aerospace & Defense industry was -9.90%. For the same industry, the average monthly price growth was -12.27%, and the average quarterly price growth was -7.66%.
Reported Earning Dates
ADCT is expected to report earnings on Aug 11, 2026.
AXON is expected to report earnings on Aug 11, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-3.88% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
@Aerospace & Defense (-9.90% weekly)Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.
| ADCT | AXON | ADCT / AXON | |
| Capitalization | 159M | 44.1B | 0% |
| EBITDA | -82.86M | 320M | -26% |
| Gain YTD | -64.589 | -3.680 | 1,755% |
| P/E Ratio | N/A | 220.58 | - |
| Revenue | 79.2M | 2.98B | 3% |
| Total Cash | 231M | 737M | 31% |
| Total Debt | 117M | 1.83B | 6% |
ADCT | AXON | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 9 | 30 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 31 Undervalued | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 59 | |
SMR RATING 1..100 | 100 | 81 | |
PRICE GROWTH RATING 1..100 | 65 | 40 | |
P/E GROWTH RATING 1..100 | 100 | 31 | |
SEASONALITY SCORE 1..100 | n/a | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ADCT's Valuation (31) in the null industry is somewhat better than the same rating for AXON (86) in the Biotechnology industry. This means that ADCT’s stock grew somewhat faster than AXON’s over the last 12 months.
AXON's Profit vs Risk Rating (59) in the Biotechnology industry is somewhat better than the same rating for ADCT (100) in the null industry. This means that AXON’s stock grew somewhat faster than ADCT’s over the last 12 months.
AXON's SMR Rating (81) in the Biotechnology industry is in the same range as ADCT (100) in the null industry. This means that AXON’s stock grew similarly to ADCT’s over the last 12 months.
AXON's Price Growth Rating (40) in the Biotechnology industry is in the same range as ADCT (65) in the null industry. This means that AXON’s stock grew similarly to ADCT’s over the last 12 months.
AXON's P/E Growth Rating (31) in the Biotechnology industry is significantly better than the same rating for ADCT (100) in the null industry. This means that AXON’s stock grew significantly faster than ADCT’s over the last 12 months.
| ADCT | AXON | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 79% | 1 day ago 66% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 74% |
| Momentum ODDS (%) | 1 day ago 89% | 1 day ago 83% |
| MACD ODDS (%) | 1 day ago 82% | 1 day ago 76% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 67% |
| TrendMonth ODDS (%) | 1 day ago 78% | 1 day ago 72% |
| Advances ODDS (%) | 7 days ago 80% | 12 days ago 74% |
| Declines ODDS (%) | 1 day ago 90% | 1 day ago 69% |
| BollingerBands ODDS (%) | 1 day ago 89% | 1 day ago 65% |
| Aroon ODDS (%) | 1 day ago 88% | 1 day ago 73% |
Advertisement
ADCT and
Correlation & Price change
A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.
| Ticker / NAME | Correlation To ADCT | 1D Price Change % | ||
|---|---|---|---|---|
| ADCT | 100% | -3.10% | ||
| QTTB - ADCT | 45% Loosely correlated | +90.72% | ||
| CLRB - ADCT | 43% Loosely correlated | -6.74% | ||
| SEPN - ADCT | 37% Loosely correlated | -4.37% | ||
| AXON - ADCT | 36% Loosely correlated | -3.32% | ||
| RCUS - ADCT | 35% Loosely correlated | -2.94% | ||
More | ||||
AXON and
Correlation & Price change
A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.
| Ticker / NAME | Correlation To AXON | 1D Price Change % | ||
|---|---|---|---|---|
| AXON | 100% | -3.32% | ||
| TECH - AXON | 61% Loosely correlated | +0.08% | ||
| VCYT - AXON | 58% Loosely correlated | +0.90% | ||
| BEAM - AXON | 57% Loosely correlated | -5.14% | ||
| SEER - AXON | 56% Loosely correlated | N/A | ||
| ADPT - AXON | 56% Loosely correlated | -0.19% | ||
More | ||||